Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Rating)’s stock price was up 3% during trading on Friday . The company traded as high as $1.84 and last traded at $1.71. Approximately 19,248 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 154,281 shares. The stock had previously closed at […]
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2023 / Allarity Therapeutics (NASDAQ:ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drugs, stenoparib and
Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX – Get Rating) – Equities research analysts at Diamond Equity issued their Q1 2023 earnings estimates for Salarius Pharmaceuticals in a research note issued on Wednesday, March 29th. Diamond Equity analyst H. Diamond expects that the company will earn ($2.65) per share for the quarter. The consensus estimate for Salarius Pharmaceuticals’ […]